'Although quite nice, I was somehow not attracted by that person': attitudes towards romantically committed opposite-sex others are immune to positive evaluative conditioning

Individuals who are motivated to find a romantic partner do not only have to detect desirable mating options but also have to prevent becoming committed to attractive but unpromising contacts. We thus propose that an acquisition of highly positive evaluations of already romantically committed opposite-sex others is prevented by self-regulatory processes. In two experiments, positive evaluative conditioning (EC) effects were obtained for facial photos (conditioned stimulus) of other opposite-sex singles when these pictures were paired with positive trait adjectives or odors (unconditioned stimulus). In line with our hypothesis, however, this positive EC effect did not obtain for faces of other persons who were presented as being already involved in a romantic relationship. The results demonstrate that the acquisition of positive attitudes during mate searching is modulated by self-regulatory processes that inhibit the emergence of futile commitments

Automatic affective-motivational regulation processes underlying supportive dyadic coping: the role of increased implicit positive attitudes toward communal goals in response to a stressed relationship partner

Background and objectives: We examined the implicit affective mechanisms underlying provision of support in intimate dyads. Specifically, we hypothesized that in individuals with high relationship satisfaction, the perception that one’s partner is stressed leads to increased implicit positive attitudes toward communal goals. In turn, this change in implicit attitudes facilitates supportive behavior. Design and methods: In two studies, we induced partner stress by instructing participants to either recall a situation where their partner was highly stressed (Study 1; N=47 university students) or imagine a specific stressful event (excessive workload; Study 2; N=85 university students). Subsequently, implicit attitudes toward communal goals were assessed with an Implicit Association Test. Results: In both studies, we found that among participants with high relationship satisfaction partner stress increases preferences for communal goals. In addition, implicit preferences for communal goals predicted stronger inclinations to engage in supportive dyadic coping (Study 2). Conclusions: The current findings provide important insights into the implicit cognitive-affective mechanics of dyadic coping. Moreover, they can explain how people manage to avoid experiencing motivational conflicts between partner-oriented and self-oriented goals in situations characterized by high partner stress

The implicit cognition of reciprocal exchange: automatic retrieval of positive and negative experiences with partners in a prisoner's dilemma game

<p>Models of reciprocity imply that cheater detection is an important prerequisite for successful social exchange. Considering the fundamental role of memory in reciprocal exchange, these theories lead to the prediction that memory for cheaters should be preferentially enhanced. Here, we examine whether information of a partner's previous behaviour in an interaction is automatically retrieved when encountering the face of a partner who previously cheated or cooperated. In two studies, participants played a sequential prisoner's dilemma game with cheaters and cooperative partners. Alternating with the game blocks, participants were asked to classify the smiling or angry facial expressions of cooperators and cheaters. Both experiments revealed congruence effects, reflecting faster identification of the smiles of cooperators (Experiments 1 and 2) and faster identification of the angry facial expressions of cheaters (Experiment 2). Our study provides evidence for the automatic retrieval of the partner's behaviour in the game, regardless of whether partners cheated or cooperated, and thus provides further evidence against the cheater detection hypothesis.</p

The Trust Game for Couples (TGC) : A new standardized paradigm to assess trust in romantic relationships

Trust between couples is a prerequisite for stable and satisfactory romantic relationships. However, there has been no valid research tool to assess partner-specific trust behavior including costly investments in the trustworthiness of the romantic partner. We here present a comprehensive validation of the newly developed Trust Game for Couples (TGC) by means of various self-report and implicit relationship-related measures. The TGC operationalizes trust by measuring an individual’s willingness to invest his or her own financial resources in pro-relationship attitudes of their romantic partner (collected by dichotomous responses to relationship-relevant items, e.g., answering yes to “I am absolutely sure that I love my partner”). Thirty-five healthy couples between 20 and 34 years completed the TGC in an interactive (both partners present), but anonymous setting (no information on the partner’s responses revealed). Trust, as measured by the TGC, correlates positively with self-reported trust, satisfaction, and felt closeness in the relationship, but not with general interpersonal trust, confirming both its convergent and discriminant validity. In addition to explicit criteria for construct validity, implicit measures of partner valence and confidence explained variance in the TGC, demonstrating that it constitutes an economical measure of implicit and explicit ingredients of trust between couples. In sum, the TGC provides a novel, specific behavioral tool for a sensitive assessment of trust in dyadic relationships with potential for numerous research fields.publishe

A Survey of Empirical Results on Program Slicing

International audienceBACKGROUND:Patients with peripheral artery disease have an increased risk of cardiovascular morbidity and mortality. Antiplatelet agents are widely used to reduce these complications.METHODS:This was a multicentre, double-blind, randomised placebo-controlled trial for which patients were recruited at 602 hospitals, clinics, or community practices from 33 countries across six continents. Eligible patients had a history of peripheral artery disease of the lower extremities (previous peripheral bypass surgery or angioplasty, limb or foot amputation, intermittent claudication with objective evidence of peripheral artery disease), of the carotid arteries (previous carotid artery revascularisation or asymptomatic carotid artery stenosis of at least 50%), or coronary artery disease with an ankle-brachial index of less than 0·90. After a 30-day run-in period, patients were randomly assigned (1:1:1) to receive oral rivaroxaban (2·5 mg twice a day) plus aspirin (100 mg once a day), rivaroxaban twice a day (5 mg with aspirin placebo once a day), or to aspirin once a day (100 mg and rivaroxaban placebo twice a day). Randomisation was computer generated. Each treatment group was double dummy, and the patient, investigators, and central study staff were masked to treatment allocation. The primary outcome was cardiovascular death, myocardial infarction or stroke; the primary peripheral artery disease outcome was major adverse limb events including major amputation. This trial is registered with ClinicalTrials.gov, number NCT01776424, and is closed to new participants.FINDINGS:Between March 12, 2013, and May 10, 2016, we enrolled 7470 patients with peripheral artery disease from 558 centres. The combination of rivaroxaban plus aspirin compared with aspirin alone reduced the composite endpoint of cardiovascular death, myocardial infarction, or stroke (126 [5%] of 2492 vs 174 [7%] of 2504; hazard ratio [HR] 0·72, 95% CI 0·57-0·90, p=0·0047), and major adverse limb events including major amputation (32 [1%] vs 60 [2%]; HR 0·54 95% CI 0·35-0·82, p=0·0037). Rivaroxaban 5 mg twice a day compared with aspirin alone did not significantly reduce the composite endpoint (149 [6%] of 2474 vs 174 [7%] of 2504; HR 0·86, 95% CI 0·69-1·08, p=0·19), but reduced major adverse limb events including major amputation (40 [2%] vs 60 [2%]; HR 0·67, 95% CI 0·45-1·00, p=0·05). The median duration of treatment was 21 months. The use of the rivaroxaban plus aspirin combination increased major bleeding compared with the aspirin alone group (77 [3%] of 2492 vs 48 [2%] of 2504; HR 1·61, 95% CI 1·12-2·31, p=0·0089), which was mainly gastrointestinal. Similarly, major bleeding occurred in 79 (3%) of 2474 patients with rivaroxaban 5 mg, and in 48 (2%) of 2504 in the aspirin alone group (HR 1·68, 95% CI 1·17-2·40; p=0·0043).INTERPRETATION:Low-dose rivaroxaban taken twice a day plus aspirin once a day reduced major adverse cardiovascular and limb events when compared with aspirin alone. Although major bleeding was increased, fatal or critical organ bleeding was not. This combination therapy represents an important advance in the management of patients with peripheral artery disease. Rivaroxaban alone did not significantly reduce major adverse cardiovascular events compared with asprin alone, but reduced major adverse limb events and increased major bleeding